ArticleFrontiers in microbiology2020
The Cultivable Bacterial Microbiota Associated to the Medicinal Plant
Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Rhizosphere bacterial and fungal community structure varies among field-grownFrontiers in microbiology · 2026Article
- Article
- Oregano Essential Oil as a Natural Plant Additive Affects Growth Performance and Serum Antibody Levels by Regulating the Rumen Microbiota of Calves.Animals : an open access journal from MDPI · 2024Article
- Antimicrobial Activity ofMolecules (Basel, Switzerland) · 2024Review
- Drought-Adapted Mediterranean Diet Plants: A Source of Bioactive Molecules Able to Give Nutrigenomic Effects per sè or to Obtain Functional Foods.International journal of molecular sciences · 2024Review
- Endophytic bacteria: a sustainable strategy for enhancing medicinal plant cultivation and preserving microbial diversity.Frontiers in microbiology · 2024Review
- Employing Genome Mining to Unveil a Potential Contribution of Endophytic Bacteria to Antimicrobial Compounds in theAntibiotics (Basel, Switzerland) · 2023Article
- Genomic, Molecular, and Phenotypic Characterization ofInternational journal of molecular sciences · 2023Article
- Biocontrol Activity of Aromatic and Medicinal Plants and Their Bioactive Components against Soil-Borne Pathogens.Plants (Basel, Switzerland) · 2023Review
- Endophytic Bacteria Associated with Origanum heracleoticum L. (Lamiaceae) SeedsMicroorganisms · 2022Article
- Secondary Metabolites Produced by Plant Growth-Promoting Bacterial Endophytes.Microorganisms · 2022Review
- Endophytic Bacteria and Essential Oil fromMicroorganisms · 2022Article
- Genomic Analysis of EndophyticMicroorganisms · 2022Article
- Antinociceptive, anti-inflammatory, and cytotoxic properties ofThe Korean journal of pain · 2022Article
- Medicinal Plants and Their Bacterial Microbiota: A Review on Antimicrobial Compounds Production for Plant and Human Health.Pathogens (Basel, Switzerland) · 2021Review
- The Microbiome of the Medicinal PlantsFrontiers in microbiology · 2021Article
- Exploring endophytes forAIMS microbiology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The insurgence of antibiotic resistance and emergence of multidrug-resistant (MDR) pathogens prioritize research to discover new antimicrobials. In this context, medicinal plants produce bioactive compounds of pharmacological interest: some extracts have antimicrobial properties that can contrast different pathogens. For such a purpose,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.